HIV type 2 is a sub species of the lentivirus HIV. HIV-2 has a slower progression rate of the disease, as well as lower rates of transmission compared to HIV-1. Often patients infected with HIV-2 have a low viral load and a slower rate of CD4 cell count decline as compared those infected with HIV-1.
Leukopaks are obtained by a donation process where blood is withdrawn from the donor via leukapheresis utilizing an aphresis machine such as the Spectra Optia. The donor’s white blood cells are selectively collected and the remaining blood is reinfused to the body.
PPA's fresh HIV-2 leukopaks are obtained by aphresis from donors with HIV-2. All of our donors are fully consented and IRB approved.
Products sold or distributed by Physicians Plasma Alliance or PPA Research Group are intended and labeled for "Research Use Only" and are never to be used in humans, human trials or used in a manner inconsistent with "Research Use Only" labeling.